反应详情

Ethyl 3-[5-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indazol-1-yl]propanoate (D5) (240 mg) was dissolved in MeOH (5 ml), treated with 2 M aqueous NaOH (5 ml) and stirred at RT overnight and vacuumed to remove the MeOH. The reaction mixture was then diluted with 1M aqueous NaOH, washed with EtOAc (×2) and acidified to pH=3. This solution was extracted with EtOAc (×3) and the combined extracts washed with brine and evaporated to give the crude product. This was purified using the MDAP system to give the title compound (13 mg) as a white solid. δH (CDCl3, 400 MHz): 1.44 (6H, d), 3.03 (2H, t), 4.68-4.75 (3H, m), 7.05 (1H, d), 7.60 (1H, d), 8.06 (1H, d), 8.11 (1H, s), 8.15 (1H, d), 8.24 (1H, s), 8.56 (1H, s). MS (ES): C21H1935ClN4O4 requires 426; found 427 (MH+).

1. customto remove the MeOH
2. additionThe reaction mixture was then diluted with 1M aqueous NaOH
3. washwashed with EtOAc (×2)
4. extractionThis solution was extracted with EtOAc (×3)
5. washthe combined extracts washed with brine
6. customevaporated
7. customto give the crude product
8. customThis was purified